Montelukast drug activity and potential against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Copertino, Dennis C; Duarte, Rodrigo R R; Powell, Timothy R; de Mulder Rougvie, Miguel; Nixon, Douglas F

Copertino, Dennis C; Duarte, Rodrigo R R; Powell, Timothy R; de Mulder Rougvie, Miguel; Nixon, Douglas F.

Copertino DC; Division of Infectious Diseases, Weill Cornell Medicine, Cornell University, New York, New York.
Duarte RRR; Division of Infectious Diseases, Weill Cornell Medicine, Cornell University, New York, New York.
Powell TR; Division of Infectious Diseases, Weill Cornell Medicine, Cornell University, New York, New York.
de Mulder Rougvie M; Division of Infectious Diseases, Weill Cornell Medicine, Cornell University, New York, New York.
Nixon DF; Division of Infectious Diseases, Weill Cornell Medicine, Cornell University, New York, New York.

J Med Virol ; 93(1): 187-189, 2021 01.

Article in English | MEDLINE | ID: covidwho-653171

Subject(s)

Acetates/therapeutic use; Antiviral Agents/therapeutic use; COVID-19 Drug Treatment; Cyclopropanes/therapeutic use; Quinolines/therapeutic use; SARS-CoV-2/drug effects; Sulfides/therapeutic use; Anti-Inflammatory Agents/therapeutic use; COVID-19/virology; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Quinolines / Sulfides / Cyclopropanes / SARS-CoV-2 / COVID-19 Drug Treatment / Acetates Limits: Humans Language: English Journal: J Med Virol Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google